Prescribed List: Changes from 1 April 2014

Information about the publication of Ministerial Decisions

A formal published “Ministerial Decision” is required as a record of the decision of a Minister (or an Assistant Minister where they have delegated authority) as they exercise their responsibilities and powers.

Ministers are elected by the States Assembly and have legal responsibilities and powers as “corporation sole” under the States of Jersey Law 2005 by virtue of their office and in their areas of responsibility, including entering into agreements, and under any legislation conferring on them powers.

An accurate record of “Ministerial Decisions” is vital to effective governance, including:

demonstrating that good governance, and clear lines of accountability and authority, are in place around decisions-making – including the reasons and basis on which a decision is made, and the action required to implement a decision
providing a record of decisions and actions that will be available for examination by States Members, and Panels and Committees of the States Assembly; the public, organisations, and the media; and as a historical record and point of reference for the conduct of public affairs

Ministers are individually accountable to the States Assembly, including for the actions of the departments and agencies which discharge their responsibilities.

The Freedom of Information Law (Jersey) Law 2011 is used as a guide when determining what information is be published. While there is a presumption toward publication to support of transparency and accountability, detailed information may not be published if, for example, it would constitute a breach of data protection, or disclosure would prejudice commercial interest.

A decision made 27 February 2014:

Decision Reference: MD-S-2014-0020
Decision Summary Title :	DS_Prescribed List PBAC 11 Feb 2014		Date of Decision Summary:	26/02/2014
Decision Summary Author:	Policy Principal		Decision Summary: Public or Exempt?	Public
Type of Report: Oral or Written?	Written		Person Giving Oral Report:	N/A
Written Report Title :	WR _Prescribed List PBAC_11 Feb 2014		Date of Written Report:	26/02/2014
Written Report Author:	Prescribing Advisor		Written Report : Public or Exempt?	Exempt clause 3.2.1 (a) (xi)
Subject: Changes to be made to the Prescribed List (Jersey) as at 1 April 2014
Decision(s): Further to Article 15, paragraphs (11) and (12), of the Health Insurance (Jersey) Law 1967, and having consulted with the Pharmaceutical Benefit Advisory Committee, the Minister decided to make amendments to the Prescribed List with effect from 1 April 2014. Apixaban tablets (2.5 mg, 5mg) for the prevention of stroke, Ivabradine (5mg, 7.5mg) for the treatment of chronic heart failure, Alverine Capsules (120mg) for the treatment of irritable bowel, Duac gel for the treatment of acne and Aerochamber Plus Spacer Device for use with pressurised inhalers will be added to the Prescribed list. The Minister decided to delete two items from the list; Asilone which has been discontinued by the manufacturer and Magnesium trisilicate which is infrequently prescribed and has a high sodium content.
Reason(s) for Decision: The Pharmaceutical Benefit Advisory Committee met on 11 February 2014 and has provided the Minister with a written report setting out its recommendations in respect of amendments to the Prescribed List. The changes reflect current evidence and expert advice, and ensure that patients in Jersey continue to have access to an appropriate range of modern, safe and effective treatments from their GPs at a proportionate cost to the Fund.
Resource Implications: The overall impact of the changes represents an anticipated cost to the Fund of less than £50,000 per annum.
Action required: Business Manager to issue public notice listing amendments and notify all approved medical practitioners and approved contractors.
Signature:		Position: Minister
Date Signed:		Date of Decision (If different from Date Signed):